Dana Pizzuti, Chief Med and Development Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 5,000 shares at $42.65 ($213K) on 2025-11-03, disclosed to the SEC on 2025-11-05.
Scheduled sale ($213k) by Chief Med and Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.65 | 4,900 | $209K | 98.0% |
| 2 | $43.27 | 100 | $4K | 2.0% |
| Total | $42.66 avg | 5,000 | $213K | 100% |
| Filing → |
| CRNX | SELL | 2025-09-04 | $161K | — | Filing → |
| CRNX | SELL | 2025-08-26 | $913K | — | Filing → |
| CRNX | SELL | 2025-08-21 | $379K | — | Filing → |